EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway

Rania Alaaeldin iD, Reham H Mohyeldin, Amany Abdlrehim Bekhit, Wafaey Gomaa iD, Qing-Li Zhao, Moustafa Fathy iD

Molecules · 2023

DOI: 10.3390/molecules28124665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Rania Alaaeldin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Vincamine. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI Grant Number (JP21K07614), JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis is a progressive, irreversible lung disease that leads to respiratory failure and death. Vincamine is an indole alkaloid obtained from the leaves of Vinca minor and acts as a vasodilator. The present study aims to investigate the protective activity of vincamine against EMT in bleomycin (BLM)-induced pulmonary fibrosis via assessing the apoptotic and TGF-β1/p38 MAPK/ERK1/2 signaling pathways. In bronchoalveolar lavage fluid, protein content, total cell count, and LDH activity were evaluated. N-cadherin, fibronectin, collagen, SOD, GPX, and MDA levels were determined in lung tissue using ELISA. Bax, p53, bcl2, TWIST, Snai1, and Slug mRNA levels were examined using qRT-PCR. Western blotting was used to assess the expression of TGF-β1, p38 MAPK, ERK1/2, and cleaved caspase 3 proteins. H & E and Masson’s trichrome staining were used to analyze histopathology. In BLM-induced pulmonary fibrosis, vincamine reduced LDH activity, total protein content, and total and differential cell count. SOD and GPX were also increased following vincamine treatment, while MDA levels were decreased. Additionally, vincamine suppressed the expression of p53, Bax, TWIST, Snail, and Slug genes as well as the expression of factors such as TGF-β1, p/t p38 MAPK, p/t ERK1/2, and cleaved caspase 3 proteins, and, at the same time, vincamine increased bcl2 gene expression. Moreover, vincamine restored fibronectin, N-Catherine, and collagen protein elevation due to BLM-induced lung fibrosis. In addition, the histopathological examination of lung tissues revealed that vincamine attenuated the fibrotic and inflammatory conditions. In conclusion, vincamine suppressed bleomycin-induced EMT by attenuating TGF-β1/p38 MAPK/ERK1/2/TWIST/Snai1/Slug/fibronectin/N-cadherin pathway. Moreover, it exerted anti-apoptotic activity in bleomycin-induced pulmonary fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisVincamineRatsAnimalsTransforming Growth Factor betaBleomycinTransforming Growth Factor beta1FibronectinsCaspase 3Epithelial-Mesenchymal TransitionTumor Suppressor Protein p53bcl-2-Associated X ProteinLungCollagenSuperoxide Dismutasep38 Mitogen-Activated Protein Kinases

Stichwörter der Autor:innen

EMTMAPKSnai1TGF-β1apoptosispulmonary fibrosisvincamine

Substanzen

Transforming Growth Factor betaBleomycinTransforming Growth Factor beta1VincamineFibronectinsCaspase 3Tumor Suppressor Protein p53bcl-2-Associated X ProteinCollagenSuperoxide Dismutase

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
  • Department of Pathology, Faculty of Medicine, Minia University, Minia 61519, Egypt.
  • Department of Radiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
  • Department of Regenerative Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

ORCID-Profile: Rania Alaaeldin, Wafaey Gomaa, Moustafa Fathy

Förderung

  • JSPS KAKENHI Grant Number (JP21K07614)
  • JSPS KAKENHI

Zitieren

APA

Alaaeldin, R., Mohyeldin, R. H., Bekhit, A. A., Gomaa, W., Zhao, Q. L., & Fathy, M. (2023). Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway. Molecules. https://doi.org/10.3390/molecules28124665

Vancouver

Alaaeldin R, Mohyeldin RH, Bekhit AA, Gomaa W, Zhao QL, Fathy M. Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway. Molecules. 2023. doi:10.3390/molecules28124665

BibTeX
@article{Alaaeldin2023,
  author = {Alaaeldin, Rania and Mohyeldin, Reham H and Bekhit, Amany Abdlrehim and Gomaa, Wafaey and Zhao, Qing-Li and Fathy, Moustafa},
  title = {Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28124665}
}
Kostenlos starten →